Danaher's Beckman Coulter Says US FDA Clears DxC 500i Clinical Analyzer-February 2024-www.financetom.com

Danaher's Beckman Coulter Says US FDA Clears DxC 500i Clinical Analyzer

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Danaher's Beckman Coulter Says US FDA Clears DxC 500i Clinical Analyzer

Mar 10, 2025 7:18 AM

09:47 AM EDT, 03/10/2025 (MT Newswires) -- Danaher's ( DHR ) Beckman Coulter Diagnostics unit said Monday its clinical chemistry and immunoassay analyzer DxC 500i received 510(k) clearance from the US Food and Drug Administration.

The DxC 500i has a throughput of up to 800 clinical chemistry tests per hour and 100 immunoassay tests per hour, the company said.

Price: 209.03, Change: -3.04, Percent Change: -1.44

Previous page： Tyler Technologies Insider Sold Shares Worth $1,894,681, According to a Recent SEC Filing Next page： Google agrees $36 million fine for anti-competitive deals with Australia telcos

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Tyler Technologies Insider Sold Shares Worth $1,894,681, According to a Recent SEC Filing

May 28, 2025

04:53 PM EDT, 05/28/2025 (MT Newswires) -- Brian K Miller, Executive Vice President and CFO, on May 23, 2025, sold 3,333 shares in Tyler Technologies ( TYL ) for $1,894,681. Following the Form 4 filing with the SEC, Miller has control over a total of 38,012 common shares of the company, with 11,231 shares held directly and 26,781 controlled indirectly....

Google agrees $36 million fine for anti-competitive deals with Australia telcos

Aug 17, 2025

SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...

Synopsys Fiscal Q2 Earnings, Revenue Rise; Sets Guidance

May 28, 2025

04:53 PM EDT, 05/28/2025 (MT Newswires) -- Synopsys ( SNPS ) reported fiscal Q2 non-GAAP earnings late Wednesday of $3.67 per diluted share, up from $3.00 a year earlier. Analysts polled by FactSet expected $3.39. Revenue for the quarter that ended April 30 was $1.60 billion, up from $1.45 billion a year earlier. Analysts surveyed by FactSet expected $1.60 billion....

C3.AI Stock Jumps After Q4 Results Top Estimates

May 28, 2025

C3.Ai Inc ( AI ) shares are surging in Wednesday’s after-hours session after the company reported better-than-expected results for the fourth quarter of fiscal 2025. Q4 Revenue: $108.7 million, versus estimates of $107.73 million Q4 Adjusted Loss: 18 cents, versus estimates of 20 cents Total revenue was up 26% year-over-year as subscription revenue climbed 9% year-over-year. C3.AI ( AI )...